Profile for Slovenia Patent: 2579854
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: 2579854
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jun 9, 2031 | Abbvie | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
⤷ Sign Up | Jun 9, 2031 | Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir |
⤷ Sign Up | Jun 9, 2031 | Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |